ClinicalTrials.Veeva

Menu

Description of Ophthalmologic Injuries in Intensive Care During the SARS-CoV2 Epidemic - COVID19 (DOCOV)

F

Fondation Ophtalmologique Adolphe de Rothschild

Status

Completed

Conditions

Sars-CoV2
Covid19

Treatments

Procedure: Ophthalmologic exam

Study type

Interventional

Funder types

NETWORK

Identifiers

NCT04385810
JDS_2020_13

Details and patient eligibility

About

The management of patients with SARS-CoV2 in respiratory distress can expose to corneal or retinal lesions induced by the stay in intensive care.

Examination by ophthalmologists would make it possible to detect the most of the ophthalmologic problems known in intensive care and to provide an early, preventive or curative therapeutic response when possible, in order to avoid irreversible visual loss.

The object of the research is to assess the presence and the importance of surface ophthalmologic lesions, the presence and the importance of retinal or optic nerve lesions, in order to improve the monitoring and primary prevention of this population

Enrollment

23 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patient SARS-CoV2 positive (RT-PCR or chest scanner)
  • hospitalized in intensive care

Exclusion criteria

  • traumatic lesion of the face or any other condition preventing any ophthalmological evaluation

Trial design

Primary purpose

Prevention

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

23 participants in 1 patient group

Ophthalmologic exam
Experimental group
Treatment:
Procedure: Ophthalmologic exam

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems